Recombinant Human RARb Protein，His

RARb, or Retinoic Acid Receptor beta, is a member of the nuclear receptor superfamily that plays a crucial role in mediating the effects of retinoic acid, a metabolite of vitamin A. This receptor is involved in various biological processes, including cell differentiation, growth regulation, and apoptosis. Studies have shown that RARb is significantly implicated in the pathology of several cancers, particularly in the context of tumor suppressor functions. Abnormal expression of RARb has been linked to tumor progression and poor prognosis in various malignancies, highlighting the importance of understanding its regulatory mechanisms and downstream signaling pathways. The research on RARb recombinant proteins aims to explore their functional roles and interactions in cellular contexts, providing insights into how RARb modulation might offer novel therapeutic strategies. By generating and studying RARb recombinant proteins in vitro and in vivo, scientists can investigate their structures, binding affinities, and effects on target genes. This research can contribute to the development of RARb-targeted therapies that could restore its function in cancer treatment and other diseases associated with retinoic acid signaling dysregulation. Overall, the study of RARb recombinant proteins is pivotal for unraveling the complexities of retinoic acid signaling and its implications in health and disease.